Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal

Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal

BackgroundThere is increasing interest in therapeutic ketosis as a potential therapy for neurodegenerative disorders–in particular, mild cognitive impairment (MCI), Alzheimer's disease (AD), and Parkinson's disease (PD)–following a proof-of-concept study in Parkinson's disease publish...

Full description

Bibliographic Details
Main Authors:	Jeffrey L. B. Bohnen, Roger L. Albin, Nicolaas I. Bohnen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Neurology
Subjects:	Alzheimer's disease mild cognitive impairment Parkinson's disease ketogenic effectiveness
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1123290/full

Similar Items

Automated Synthesis of 18F-BCPP-EF {2-tert-Butyl-4-Chloro-5-{6-[2-(2[18F]fluoroethoxy)-Ethoxy]-Pyridin-3-ylmethoxy}-2H-Pyridazin-3-One for Imaging of Mitochondrial Complex 1 in Parkinson’s Disease
by: Tanpreet Kaur, et al.
Published: (2022-03-01)

Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach
by: Sygrid van der Zee, et al.
Published: (2022-10-01)

Golexanolone reduces glial activation in the striatum and improves non-motor and some motor alterations in a rat model of Parkinson's disease
by: Paula Izquierdo-Altarejos, et al.
Published: (2024-06-01)

Brain Dynamics Underlying Preserved Cycling Ability in Patients With Parkinson’s Disease and Freezing of Gait
by: Teja Licen, et al.
Published: (2022-06-01)

Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease
by: Jaimie Barr, et al.
Published: (2024-09-01)

Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection
by: Prabesh Kanel, et al.
Published: (2023-11-01)

Emerging non-invasive therapeutic approaches targeting hypocholinergic neural systems in Parkinson’s disease
by: Nicolaas I Bohnen, et al.
Published: (2023-01-01)

Altered cerebellar connectivity in Parkinson’s patients ON and OFF L-DOPA medication
by: Sara B Festini, et al.
Published: (2015-04-01)

Serotonin transporter density in isolated rapid eye movement sleep behavioral disorder
by: Mark Garwood, et al.
Published: (2024-01-01)

Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson’s disease
by: Youngbin Kwak, et al.
Published: (2010-09-01)

The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study.
by: Irene M Lelieveld, et al.
Published: (2012-01-01)

Regional serotonin terminal density in aging human brain: A [11C]DASB PET study
by: Prabesh Kanel, et al.
Published: (2023-01-01)

GABA<sub>A</sub> Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson’s Disease
by: Nicolaas I. Bohnen, et al.
Published: (2023-12-01)

L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson’s disease: a resting state fMRI study
by: Youngbin eKwak, et al.
Published: (2012-07-01)

Motor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [18F]FDG PET-CT Study
by: Nicolaas I. Bohnen, et al.
Published: (2016-01-01)

Beta–Gamma Phase-Amplitude Coupling as a Non-Invasive Biomarker for Parkinson’s Disease: Insights from Electroencephalography Studies
by: Tisa Hodnik, et al.
Published: (2024-03-01)

Feasibility and behavioral effects of prolonged static and dynamic standing as compared to sitting in older adults with type 2 diabetes mellitus
by: Uros Marusic, et al.
Published: (2020-06-01)

Sensitivity to and Control of Distraction: Distractor-Entrained Oscillation and Frontoparietal EEG Gamma Synchronization
by: Taylor Brown, et al.
Published: (2024-06-01)

Effects of ketogenic diet on cognitive function of patients with Alzheimer's disease: a systematic review and meta-analysis
by: Liyang Rong, et al.
Published: (2024-08-01)

Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study
by: Prabesh Kanel, et al.
Published: (2022-01-01)

Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
by: Chatkaew Pongmala, et al.
Published: (2024-01-01)

A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer’s disease
by: Alison Buchholz, et al.
Published: (2024-03-01)

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
by: Shuai Xiang, et al.
Published: (2022-02-01)

Ketogenic diets and Alzheimer’s disease
by: Klaus W. Lange, et al.
Published: (2017-03-01)

The Effect of the Ketogenic Diet on the Therapy of Neurodegenerative Diseases and Its Impact on Improving Cognitive Functions
by: Klaudia Grochowska, et al.
Published: (2022-05-01)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
by: Alfonso Delgado-Álvarez, et al.
Published: (2023-05-01)

Erfolgskontrolle ausgewählter Energieprognosen
by: Ulrich Bohnen
Published: (1978-11-01)

RETRACTED: Associations of vitamin D receptor polymorphisms with risk of Alzheimer’s disease, Parkinson’s disease, and mild cognitive impairment: a systematic review and meta-analysis
by: Yanjun Du, et al.
Published: (2024-04-01)

Improving efficacy of repetitive transcranial magnetic stimulation for treatment of Parkinson disease gait disorders
by: Rupsha Panda, et al.
Published: (2024-08-01)

Cognitive Profiles of Patients with Mild Cognitive Impairment or Dementia in Alzheimer's or Parkinson's Disease
by: Helmut Hildebrandt, et al.
Published: (2013-04-01)

Multisensory mechanisms of gait and balance in Parkinson’s disease: an integrative review
by: Stiven Roytman, et al.
Published: (2025-01-01)

Mineralização de palha de milho e adsorção de carbono, cálcio, magnésio e potássio em substratos com caulinita natural e goethita sintética
by: L. S. Silva, et al.
Published: (2001-06-01)

Liberação de nutrientes durante a decomposição de palha de aveia preta (Avena strigosa) com diferentes teores de silício
by: L. S. Silva, et al.
Published: (2001-06-01)

A Potential Role for the Ketogenic Diet in Alzheimer’s Disease Treatment: Exploring Pre-Clinical and Clinical Evidence
by: Tadeu P. D. Oliveira, et al.
Published: (2023-12-01)

Could the ketogenic diet offer hope in management of neurological diseases?
by: Büşra Atabilen, et al.
Published: (2025-02-01)

Mini-review: Retarding aging in murine genetic models of neurodegeneration
by: Roger L. Albin, et al.
Published: (2016-01-01)

Surgical Site Surveillance: Quality Improvement or Waste of Time?
by: John MA Bohnen
Published: (1994-01-01)

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
by: Alfonso Delgado-Álvarez, et al.
Published: (2023-01-01)

Deep Learning Identifies Digital Biomarkers for Self-Reported Parkinson's Disease
by: Hanrui Zhang, et al.
Published: (2020-06-01)

Associations of Serum Isoleucine with Mild Cognitive Impairment and Alzheimer’s Disease
by: Xiao-jun Jing, et al.
Published: (2024-09-01)